• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心输出量正常和心输出量降低患者的超声心动图检查结果与实验室血清生物标志物之间的关系

Relationship between echocardiographic findings and laboratory serum biomarkers in patients with and without low cardiac output.

作者信息

Khalilian Mohammad Reza, Sabri Mohammad Reza, Nikyar Abdolrasoul, Javanmard Shaghayegh Haghjooy

机构信息

Department of Pediatrics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

J Res Med Sci. 2011 Nov;16(11):1397-404.

PMID:22973339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3430055/
Abstract

BACKGROUND

Cardiac dysfunction is seen in many patients and could be evaluated with echocardiography and serum biomarkers. The aim of this study was evaluation of the relationship between echocardiographic findings and laboratory serum biomarkers in children with and without low cardiac output.

METHODS

Thirty patients older than 1 month with and without low cardiac output were enrolled in this study. It composed of 13 patients with dilated cardiomyopathy (DCM), 7 with end stage renal disease (ESRD) and 10 who had a Fontan operation. Echocardiography was performed with emphasis on shortening fraction (SF) and ejection fraction (EF). Blood samples were collected for measurement of atrial natriuretic peptide (ANP), high sensitivity C-reactive protein (hs-CRP) and alkaline phosphatase (Alk-P). Both echocardiographic findings and laboratory data were compared with control levels in twenty-seven normal children. Pearson correlation and regression analysis were conducted to evaluate the aforementioned associations.

RESULTS

The mean of ANP and hs-CRP in the case group was statistically higher than control group (p < 0.001). The mean of ANP and hs-CRP were different in all groups (p < 0.001). There was a reverse linear regression between the SF and ANP in the case group (r = -0.594, p < 0.001).

CONCLUSIONS

Determination of the plasma ANP and hs-CRP level may be helpful for decisions related to early diagnosis of patient with low cardiac output.

摘要

背景

许多患者存在心脏功能障碍,可通过超声心动图和血清生物标志物进行评估。本研究的目的是评估有无低心输出量的儿童超声心动图检查结果与实验室血清生物标志物之间的关系。

方法

本研究纳入了30例年龄大于1个月、有无低心输出量的患者。其中包括13例扩张型心肌病(DCM)患者、7例终末期肾病(ESRD)患者和10例接受Fontan手术的患者。进行超声心动图检查时重点关注缩短分数(SF)和射血分数(EF)。采集血样以测量心房利钠肽(ANP)、高敏C反应蛋白(hs-CRP)和碱性磷酸酶(Alk-P)。将超声心动图检查结果和实验室数据与27例正常儿童的对照水平进行比较。进行Pearson相关性和回归分析以评估上述关联。

结果

病例组中ANP和hs-CRP的平均值在统计学上高于对照组(p < 0.001)。所有组中ANP和hs-CRP的平均值均不同(p < 0.001)。病例组中SF与ANP之间存在反向线性回归关系(r = -0.594,p < 0.001)。

结论

测定血浆ANP和hs-CRP水平可能有助于做出与低心输出量患者早期诊断相关的决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5a/3430055/336030bd0845/JRMS-16-1397-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5a/3430055/f04b759f6915/JRMS-16-1397-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5a/3430055/336030bd0845/JRMS-16-1397-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5a/3430055/f04b759f6915/JRMS-16-1397-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf5a/3430055/336030bd0845/JRMS-16-1397-g004.jpg

相似文献

1
Relationship between echocardiographic findings and laboratory serum biomarkers in patients with and without low cardiac output.心输出量正常和心输出量降低患者的超声心动图检查结果与实验室血清生物标志物之间的关系
J Res Med Sci. 2011 Nov;16(11):1397-404.
2
BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.B型利钠肽和心房钠尿肽作为左心室收缩功能不全性心力衰竭的诊断和预测标志物。
J Renin Angiotensin Aldosterone Syst. 2004 Sep;5(3):121-9. doi: 10.3317/jraas.2004.028.
3
NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.N末端B型利钠肽原(NT-proBNP)而非心房钠尿肽(ANP)和C反应蛋白,可预测接受肺静脉隔离术患者的阵发性心房颤动。
J Interv Card Electrophysiol. 2012 Jan;33(1):93-100. doi: 10.1007/s10840-011-9606-9. Epub 2011 Sep 21.
4
Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.特发性动脉高血压患者的心房利钠肽、脑利钠肽及内皮素-1浓度:与所选形态学参数的相关性
Clin Exp Hypertens. 2007 Apr;29(3):149-64. doi: 10.1080/10641960701361593.
5
Depressed Corin Levels Indicate Early Systolic Dysfunction Before Increases of Atrial Natriuretic Peptide/B-Type Natriuretic Peptide and Heart Failure Development.Corin水平降低表明在心房利钠肽/B型利钠肽升高及心力衰竭发生之前就已出现早期收缩功能障碍。
Hypertension. 2016 Feb;67(2):362-7. doi: 10.1161/HYPERTENSIONAHA.115.06300. Epub 2015 Dec 14.
6
The role of biomarkers in dilated cardiomyopathy: Assessment of clinical severity and reverse remodeling.生物标志物在扩张型心肌病中的作用:临床严重程度评估及逆向重构
Rev Port Cardiol. 2017 Oct;36(10):709-716. doi: 10.1016/j.repc.2017.02.015. Epub 2017 Oct 6.
7
Pre-Procedural Serum Atrial Natriuretic Peptide Levels Predict Left Atrial Reverse Remodeling After Catheter Ablation in Patients With Atrial Fibrillation.术前血清心房利钠肽水平可预测心房颤动患者导管消融术后左心房逆向重构
JACC Clin Electrophysiol. 2016 Apr;2(2):151-158. doi: 10.1016/j.jacep.2015.12.010. Epub 2016 Jan 8.
8
[Plasma cardiac natriuretic peptide as a biological marker of recurrence of atrial fibrillation in elderly people].[血浆心钠素作为老年人房颤复发的生物学标志物]
Nihon Ronen Igakkai Zasshi. 2000 Jul;37(7):535-40. doi: 10.3143/geriatrics.37.535.
9
Longitudinal patterns of N-terminal pro B-type natriuretic peptide, troponin T, and C-reactive protein in relation to the dynamics of echocardiographic parameters in heart failure patients.心力衰竭患者 N 末端 pro B 型利钠肽、肌钙蛋白 T 和 C 反应蛋白与超声心动图参数动态变化的关系的纵向模式。
Eur Heart J Cardiovasc Imaging. 2020 Sep 1;21(9):1005-1012. doi: 10.1093/ehjci/jez242.
10
Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis.持续升高的C反应蛋白可能预示着维持性血液透析患者的心脏肥大和功能障碍。
Am J Nephrol. 2005 May-Jun;25(3):189-95. doi: 10.1159/000085585. Epub 2005 Apr 29.

引用本文的文献

1
Can atrial natriuretic peptides measurement diagnose heart failure at different age groups?心房利钠肽检测能否诊断不同年龄组的心力衰竭?
J Res Med Sci. 2012 Jan;17(1):116-7.

本文引用的文献

1
Natriuretic peptides in common valvular heart disease.常见瓣膜性心脏病中的利钠肽。
J Am Coll Cardiol. 2010 May 11;55(19):2034-48. doi: 10.1016/j.jacc.2010.02.021.
2
Variability of high-sensitivity C-reactive protein in chronic heart failure.慢性心力衰竭患者高敏C反应蛋白的变异性
Cardiology. 2009;113(3):180-3. doi: 10.1159/000189799. Epub 2009 Jan 9.
3
Cardiac physiopathology and alkaline phosphatase.心脏生理病理学与碱性磷酸酶
Pediatr Cardiol. 2009 Jan;30(1):91. doi: 10.1007/s00246-008-9339-4. Epub 2008 Dec 2.
4
Serum alkaline phosphatase reflects post-Fontan hemodynamics in children.血清碱性磷酸酶反映儿童Fontan术后的血流动力学情况。
Pediatr Cardiol. 2009 Feb;30(2):138-45. doi: 10.1007/s00246-008-9292-2. Epub 2008 Aug 7.
5
Risk stratification in neonates and infants submitted to cardiac surgery with cardiopulmonary bypass: a multimarker approach combining inflammatory mediators, N-terminal pro-B-type natriuretic peptide and troponin I.接受体外循环心脏手术的新生儿和婴儿的风险分层:一种结合炎症介质、N 末端 B 型利钠肽原和肌钙蛋白 I 的多标志物方法。
Cytokine. 2008 Jun;42(3):317-24. doi: 10.1016/j.cyto.2008.03.005. Epub 2008 Apr 15.
6
N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery.接受心脏手术的充血性心力衰竭儿科患者的N末端B型利钠肽水平
J Thorac Cardiovasc Surg. 2008 Jan;135(1):98-105. doi: 10.1016/j.jtcvs.2007.08.012.
7
Atrial natriuretic peptide: could it be a marker for postoperative recurrent effusions after Fontan circulation in complex congenital heart defects?心房利钠肽:它能否作为复杂先天性心脏病Fontan循环术后复发性积液的标志物?
ASAIO J. 2006 Sep-Oct;52(5):543-8. doi: 10.1097/01.mat.0000235275.65027.1d.
8
The effect of altering haemodynamics on the plasma concentrations of natriuretic peptides in heart failure.改变血流动力学对心力衰竭患者利钠肽血浆浓度的影响。
Eur J Heart Fail. 2006 Oct;8(6):628-33. doi: 10.1016/j.ejheart.2005.11.018. Epub 2006 Feb 7.
9
Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy.
Acta Paediatr. 2004 Mar;93(3):340-5. doi: 10.1080/08035250410022756.
10
Role of C-reactive protein in cardiovascular disease.
Ann Pharmacother. 2004 Jan;38(1):110-8. doi: 10.1345/aph.1D203.